These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 19132960)

  • 1. Preface: treatment optimization in schizophrenia through active patient management - proceedings from two European consensus meetings.
    Leucht S; van Os J
    Acta Psychiatr Scand Suppl; 2009; (438):5-6. PubMed ID: 19132960
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment optimisation in schizophrenia through active patient management, proceedings from two European consensus meetings. Epilogue.
    Steffen S
    Acta Psychiatr Scand Suppl; 2009; (438):40. PubMed ID: 19132966
    [No Abstract]   [Full Text] [Related]  

  • 3. Connecting patient needs with treatment management.
    Kerwin R
    Acta Psychiatr Scand Suppl; 2009; (438):33-9. PubMed ID: 19132965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Letter to the editor: on the articles by Klimitz H. "Psychoeducation in schizophrenic disorders--psychotherapy or 'infiltration'?" and Bäuml J. "Psychoeducation from a psychiatric-psychotherapeutic point of view". Psychiat Prax 2006; 33: 372-382 ].
    Böhme F
    Psychiatr Prax; 2007 Mar; 34(2):101-2. PubMed ID: 17390267
    [No Abstract]   [Full Text] [Related]  

  • 5. Perspectives on treatment needs in schizophrenia.
    Meise U; Fleischhacker WW
    Br J Psychiatry Suppl; 1996 May; (29):9-16. PubMed ID: 8733818
    [No Abstract]   [Full Text] [Related]  

  • 6. [Life planning and psychosis--treatment of schizophrenia in unusual circumstances].
    Jung S
    Psychiatr Prax; 1996 May; 23(3):144-5. PubMed ID: 8711008
    [No Abstract]   [Full Text] [Related]  

  • 7. Implications for the pharmacotherapy of schizophrenia.
    Rep Group Adv Psychiatry; 1992; (134):35-58. PubMed ID: 1348372
    [No Abstract]   [Full Text] [Related]  

  • 8. ["Higher outcomes"--optimizing therapy of schizophrenia].
    Rüther E
    Krankenpfl J; 2004; 42(5-6):151. PubMed ID: 15527215
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term management of schizophrenic disorders].
    Canceil O
    Encephale; 2007 Jun; 33 Pt 3():S395-8. PubMed ID: 19101358
    [No Abstract]   [Full Text] [Related]  

  • 10. [Quality assurance in the psychiatric hospital--joint medical-pharmaceutical visits].
    Reinbold H; Trenckmann U
    Psychiatr Prax; 1992 Jul; 19(4):96-9. PubMed ID: 1354882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The (new) definition of compliance].
    Arolt V
    Krankenpfl J; 2005; 43(7-10):214-5. PubMed ID: 16515287
    [No Abstract]   [Full Text] [Related]  

  • 12. Interrater reliability levels of multiple clinical examiners in the evaluation of a schizophrenic patient: quality of life, level of functioning, and neuropsychological symptomatology.
    Cicchetti DV; Rosenheck R; Showalter D; Charney D; Cramer J
    Clin Neuropsychol; 1999 May; 13(2):157-70. PubMed ID: 10949157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The intricacy of the ordinary.
    Sørensen T
    Br J Psychiatry Suppl; 1994 Apr; (23):108-14; discussion 121-2. PubMed ID: 8037894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multi-referential approach to schizophrenia in daily institutional management].
    Hayat M
    Encephale; 1996 Oct; 22 Spec No 3():80-1. PubMed ID: 8954283
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rehabilitation in schizophrenia--guidelines for including psychosocial measures].
    Katschnig H
    Wien Med Wochenschr; 1998; 148(11-12):273-80. PubMed ID: 9746970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Illness intrusiveness and subjective well-being in schizophrenia.
    Bettazzoni M; Zipursky RB; Friedland J; Devins GM
    J Nerv Ment Dis; 2008 Nov; 196(11):798-805. PubMed ID: 19008730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of schizophrenia with "atypical antipsychotic drugs". Quality of life as a measure of treatment success].
    Krankenpfl J; 2002; 40(7-9):230-1. PubMed ID: 12514869
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimal treatment strategies to enhance recovery from schizophrenia.
    Falloon IR; Held T; Roncone R; Coverdale JH; Laidlaw TM
    Aust N Z J Psychiatry; 1998 Feb; 32(1):43-9. PubMed ID: 9565182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent medication, coping and psychotherapy. Interactions in relapse prevention and course modification.
    Müller P; Bandelow B; Gaebel W; Köpcke W; Linden M; Müller-Spahn F; Pietzcker A; Schaefer E; Tegeler J
    Br J Psychiatry Suppl; 1992 Oct; (18):140-4. PubMed ID: 1356364
    [No Abstract]   [Full Text] [Related]  

  • 20. [Quality of life and daily coping of chronic schizophrenic patients. Results of a qualitative pilot study].
    Kühn A; Rosendahl W; Hennig H
    Psychother Psychosom Med Psychol; 1997 Feb; 47(2):64-71. PubMed ID: 9157470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.